Finance

Beta
Lists
DRTS:NASDAQ
Alpha Tau Medical Ltd
$9.80
-2.29%
(-0.23) 1D
$9.70
-1.02% (-0.10)
After hours
Closed: Jun 23, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DRTS...
Open
$9.47
High
$10.16
Low
$9.47
Mkt. cap
885.19M
Avg. vol.
1.08M
Volume
604.63K
52-wk high
$11.62
52-wk low
$2.87
EPS
-$0.66
Beta
1.19
Shares outstanding
88.01M
No. of employees
121
Open
$9.47
High
$10.16
Low
$9.47
Mkt. cap
885.19M
Avg. vol.
1.08M
Volume
604.63K
52-wk high
$11.62
52-wk low
$2.87
EPS
-$0.66
Beta
1.19
Shares outstanding
88.01M
No. of employees
121
News stories
From sources across the web
About Alpha Tau Medical Ltd
CEO-
Employees121
Founded2015
Headquarters-
SectorMedical device
Websitealphatau.com
Analyst Ratings
Based on 4 analysts giving stock ratings to DRTS in the past 3 months
Strong Buy
Buy
3
Hold
1
Sell
0
12 month forecast
Based on 4 Wall Street analysts offering 12 month price targets for DRTS in the last 3 months.
Highest
Current $9.80
$17.00 (+73.47%)
Average
$13.50 (+37.76%)
Lowest
$8.00 (-18.37%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Yi Chen
H.C. Wainwright
Buy
Reiterated
$15.00
+53.1%
06/15/2026
Lukas Shumway
Barclays
Buy
Maintained
$17.00
+73.5%
06/04/2026
Unknown Analyst
Barclays
Buy
Initiated
$15.00
+53.1%
05/28/2026
Jason Bednar
Piper Sandler
Hold
Reiterated
$8.00
-18.4%
05/19/2026
Jeffrey Cohen
Ladenburg Thalmann & Co.
Buy
Reiterated
$14.00
+42.9%
05/12/2026
Yigal Nochomovitz
Citi
Buy
Reiterated
$9.00
-8.2%
03/10/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
7.01M
8.31M
9.58M
10.98M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.64M
2.42M
3.03M
2.34M
Operating expense
9.65M
10.73M
12.60M
13.31M
Total operating expenses
9.65M
10.73M
12.60M
13.31M
Operating income
-9.65M
-10.73M
-12.60M
-13.31M
Other non operating income
-475.00K
475.00K
-2.09M
-
EBT including unusual items
-10.05M
-11.69M
-12.17M
-22.95M
EBT excluding unusual items
-10.05M
-11.69M
-12.17M
-22.95M
Income tax expense
65.00K
-8.00K
-35.00K
-11.00K
Effective tax rate
-0.65%
0.07%
0.29%
0.05%
Other operating expenses
-
-
-
-
Net income
-10.11M
-11.69M
-12.14M
-22.94M
Net profit margin
-
-
-
-
Earnings per share
-0.13
-0.14
-0.14
-0.26
Interest and investment income
1.13M
-
4.14M
-
Interest expense
-156.00K
-2.34M
-
-9.64M
Net interest expenses
976.00K
-2.34M
4.14M
-9.64M
Depreciation and amortization charges
-
-
-
-
EBITDA
-9.38M
-10.45M
-12.29M
-13.00M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer